trans,trans-1,5-Bis[4-(trifluoromethyl)phenyl]-1,4-pentadien-3-one>98.0%(HPLC)200mg

2,4-Dihydroxy-6-methoxyquinoline, 95.0%, 5g

2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purine-6,8(7H,9H)-dione, 95.0%, 250mg

2-Bromo-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridine, 95.0%, 5g

3,6-Dimethyl-9H-carbazole, 95.0%, 5g

4-(((3,5-Dimethyl-1H-pyrazol-1-yl)methyl)amino)benzoic acid, 95%, 100mg

1-Naphthol, 95.0%, 100g

N-(tert-Butoxycarbonyl)-4-methoxy-D-phenylalanine>98.0%(T)1g

Amifloxacin, 99.23%, 10mg

2-[(4-methyl-2-quinolinyl)thio]propanoic acid, 95.0%, 5g

Methyl 5-bromo-3,4-dimethoxy-2-methylbenzoate, 100mg

PCR individual vials Mμlti®, colorless, 500 µl 1000 pcs

Eriochrome blue black R (CI 15705), for complexometry, 100 g, glass packaging